Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | BMY:NYQ since announced | Transaction value |
---|---|---|
RayzeBio Inc | -7.63% | 4.21bn |
Karuna Therapeutics Inc | -5.77% | 14.40bn |
LianBio-Mavacamten Greater China Rights | -13.75% | 350.00m |
Mirati Therapeutics Inc | -14.75% | 5.12bn |
Data delayed at least 15 minutes, as of Apr 18 2024 21:10 BST.